BioLight Life Sciences (BioLight Life Sciences) Total Stockholders Equity : $7.78 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is BioLight Life Sciences Total Stockholders Equity?

BioLight Life Sciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $7.78 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioLight Life Sciences's Book Value per Share for the quarter that ended in Dec. 2023 was $0.13. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioLight Life Sciences's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

BioLight Life Sciences Total Stockholders Equity Historical Data

The historical data trend for BioLight Life Sciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLight Life Sciences Total Stockholders Equity Chart

BioLight Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

17.99

15.47

15.86

13.89

7.78

BioLight Life Sciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															15.86	16.52	13.89	-	7.78

BioLight Life Sciences (NAS:BOLT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioLight Life Sciences's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7.779	-	0)	/	58.851
	=	0.13

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioLight Life Sciences's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.024	+	0)	/	7.779
	=	0.00

BioLight Life Sciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioLight Life Sciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioLight Life Sciences (BioLight Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLight Life Sciences Ltd (NAS:BOLT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

BOLT:Israel

Address

Kiryat Atidim, Building 7, Entrance 1, 2nd Floor, Tel-Aviv, ISR, 6158101

Website

http://www.bio-light.co.il

BioLight Life Sciences Ltd is an emerging global ophthalmic company. It is engaged in the discovery, development, and commercialization of products and product candidates which address ophthalmic conditions, including glaucoma, dry eye syndrome and age-related macular degeneration. The firm's products include ioptimate, eye-d technology, and diagnostear. The company has the Eye cluster and the Cancer diagnostics cluster operating segments. It derives the majority of its revenues from the Eye cluster segment.